These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1004 related articles for article (PubMed ID: 20706656)

  • 1. DAMPening inflammation by modulating TLR signalling.
    Piccinini AM; Midwood KS
    Mediators Inflamm; 2010; 2010():. PubMed ID: 20706656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.
    Goh FG; Midwood KS
    Rheumatology (Oxford); 2012 Jan; 51(1):7-23. PubMed ID: 21984766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor--a potent driving force behind rheumatoid arthritis.
    Takagi M
    J Clin Exp Hematop; 2011; 51(2):77-92. PubMed ID: 22104306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of TLRs in neutrophil activation.
    Prince LR; Whyte MK; Sabroe I; Parker LC
    Curr Opin Pharmacol; 2011 Aug; 11(4):397-403. PubMed ID: 21741310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like Receptors in the Vascular System: Sensing the Dangers Within.
    Goulopoulou S; McCarthy CG; Webb RC
    Pharmacol Rev; 2016 Jan; 68(1):142-67. PubMed ID: 26721702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Intriguing Role of TLR Accessory Molecules in Cardiovascular Health and Disease.
    Bezhaeva T; Karper J; Quax PHA; de Vries MR
    Front Cardiovasc Med; 2022; 9():820962. PubMed ID: 35237675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danger of frustrated sensors: Role of Toll-like receptors and NOD-like receptors in aseptic and septic inflammations around total hip replacements.
    Takagi M; Takakubo Y; Pajarinen J; Naganuma Y; Oki H; Maruyama M; Goodman SB
    J Orthop Translat; 2017 Jul; 10():68-85. PubMed ID: 29130033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of toll-like receptors in chronic inflammation.
    Drexler SK; Foxwell BM
    Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity.
    Frevert CW; Felgenhauer J; Wygrecka M; Nastase MV; Schaefer L
    J Histochem Cytochem; 2018 Apr; 66(4):213-227. PubMed ID: 29290139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking oxidative stress to inflammation: Toll-like receptors.
    Gill R; Tsung A; Billiar T
    Free Radic Biol Med; 2010 May; 48(9):1121-32. PubMed ID: 20083193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Matrix-Derived Damage-Associated Molecular Patterns (DAMP): Implications in Systemic Sclerosis and Fibrosis.
    Bale S; Verma P; Varga J; Bhattacharyya S
    J Invest Dermatol; 2023 Oct; 143(10):1877-1885. PubMed ID: 37452808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DAMPs as mediators of sterile inflammation in aging-related pathologies.
    Feldman N; Rotter-Maskowitz A; Okun E
    Ageing Res Rev; 2015 Nov; 24(Pt A):29-39. PubMed ID: 25641058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
    Raby AC; González-Mateo GT; Williams A; Topley N; Fraser D; López-Cabrera M; Labéta MO
    Kidney Int; 2018 Aug; 94(2):346-362. PubMed ID: 29861057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension.
    McCarthy CG; Goulopoulou S; Wenceslau CF; Spitler K; Matsumoto T; Webb RC
    Am J Physiol Heart Circ Physiol; 2014 Jan; 306(2):H184-96. PubMed ID: 24163075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease.
    Jung JY; Kim JW; Suh CH; Kim HA
    Front Immunol; 2020; 11():583513. PubMed ID: 33224145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors in atherosclerosis.
    Falck-Hansen M; Kassiteridi C; Monaco C
    Int J Mol Sci; 2013 Jul; 14(7):14008-23. PubMed ID: 23880853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-Like Receptors, Infections, and Rheumatoid Arthritis.
    Arleevskaya MI; Larionova RV; Brooks WH; Bettacchioli E; Renaudineau Y
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):172-181. PubMed ID: 31144208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of toll-like receptors in systemic sclerosis.
    Ciechomska M; Cant R; Finnigan J; van Laar JM; O'Reilly S
    Expert Rev Mol Med; 2013 Aug; 15():e9. PubMed ID: 23985302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Toll-like receptors signal: what we know and what we don't know.
    O'Neill LA
    Curr Opin Immunol; 2006 Feb; 18(1):3-9. PubMed ID: 16343886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
    Kumar V
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.